The Scientific Research Team at Rénibus Therapeutics is dedicated to advancing innovative therapies for cardio-renal diseases. Comprising experts in various fields, the team focuses on conducting rigorous scientific studies, translating research findings into clinical applications, and developing diagnostic tests to improve kidney disease outcomes. Their collaborative efforts aim to drive pre-clinical and clinical advancements, ultimately transforming patient care in this critical area.
Alexander Zarbock
Scientific Advisor
Alpesh Amin
Scientific Advisor
Andrew Shaw
Scientific Advisor
Glenn M. Chertow
Scientific Advisor
Jean-Claude Tardif
Scientific Advisor
Kevin W. Lobdell
Scientific Advisor
Patrick T. Murray
Scientific Advisor
Rakesh Arora
Scientific Advisor
Ravi Thadhani,
Scientific Advisor
Richard A. Zager
SVP, Tranlational Research
View all